Sentynl will acquire full rights to the investigational drug candidate, Progerinin (SLC-D011), adding to its commercial portfolio of rare and ultra-rare disease products AHMEDABAD, India and SOLANA ...

Zydus Lifesciences' subsidiary, Sentynl Therapeutics, has licensed the experimental molecule Progerinin to treat ...

Sentynl will obtain full rights to Progerinin after specified milestones, while immediately collaborating with PRG S&T to accelerate clinical development for HGPS. Progerinin is designed to inhibit ...

Sentynl will acquire full rights to Progerinin for HGPS, provided certain milestones are achieved.

TikTok star Beandri Booysen, known for her inspirational social media videos, has died. She was 19. On Wednesday, Dec. 18, Beandri's mom, Bea Booysen, confirmed on Facebook that the teenager had died.

In today's Pharmaceutical Executive Daily, ongoing conflict in the Middle East is straining pharmaceutical supply routes to ...

Using new technology, researchers from Texas found that they could reverse many markers of aging in cells from children with progeria, a rare genetic disease that causes rapid aging and early death.

Sentynl Therapeutics licenses Progerinin from PRG S&T for Hutchinson-Gilford Progeria Syndrome. Clinical trial data expected ...

Tiffany Wedekind is now believed to be one of the oldest living survivors of progeria, more commonly known as rapid aging disease, or Benjamin Button disease. At 46 years old, she has exceeded the ...

Progeria, an ultrarare and fatal genetic disease characterized by rapid aging, can affect children and young adults.

(Gray News) – The longest-living survivor of progeria has died at the age of 28. In a Facebook post, the Progeria Research Foundation announced that Sammy Basso passed away Saturday. “Sammy was the ...